Sanofi Pasteur MSD appoints Jean-Paul Kress president
This article was originally published in Scrip
Sanofi-Pasteur MSD, a vaccines company made up of the vaccines division of Sanofi, Sanofi Pasteur, and MSD, known as Merck in the US, has appointed Dr Jean-Paul Kress president. Dr Kress is a board member of LEEM, the French Pharma Industry Association, and was previously vice-president and general manager for Gilead France.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.